Cargando…
A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Purpose: To investigate the safety, tolerability, and pharmacokinetics of trabodenoson, a highly selective adenosine mimetic targeting the adenosine A(1) receptor. Methods: In Part 1, 60 healthy adult volunteers were randomized to 14 days of twice-daily topical monocular application of placebo or tr...
Autores principales: | Laties, Alan, Rich, Cadmus C., Stoltz, Randall, Humbert, Vernon, Brickman, Chaim, McVicar, William, Baumgartner, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069726/ https://www.ncbi.nlm.nih.gov/pubmed/27046445 http://dx.doi.org/10.1089/jop.2015.0147 |
Ejemplares similares
-
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
por: Myers, Jonathan S., et al.
Publicado: (2016) -
Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
por: Guo, Yan, et al.
Publicado: (2019) -
Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
por: Miyoshi, So, et al.
Publicado: (2019) -
Trabodenoson, an Adenosine Mimetic With A(1) Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice
por: Li, Guorong, et al.
Publicado: (2018) -
A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers
por: Perkins, Daniel, et al.
Publicado: (2020)